Ownership history in MORGAN STANLEY · 8 quarters on record
This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in BIOAFFINITY TECHNOLOGIES INC (BIAF). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 3 | — | 0% | 0.00% | $4 | $1.18 |
| 2025 Q3 | REDUCED | 3 | -97 | -97.0% | 0.00% | $9 | $2.96 |
| 2025 Q2 | REDUCED | 100 | -200 | -66.7% | 0.00% | $29 | $8.61 |
| 2025 Q1 | REDUCED | 300 | -200 | -40.0% | 0.00% | $78 | $7.80 |
| 2024 Q4 | REDUCED | 500 | -4,461 | -89.9% | 0.00% | $455 | $27.30 |
| 2024 Q3 | ADDED | 4,961 | +3,961 | +396.1% | 0.00% | $10K | $62.40 |
| 2024 Q2 | ADDED | 1,000 | +997 | +33233.3% | 0.00% | $2K | $64.80 |
| 2022 Q4 | INITIATED | 3 | — | — | 0.00% | $5 | — |
As of 2025 Q4 — sorted by position size